Company:  ORAMED PHARMACEUTICALS IN ... (ORMP)
Form Type:  10-Q
Filing Date:  1/14/2014 
CIK:  0001176309 
Address:  HI-TECH PARK 2/4 GIVAT-RAM
PO BOX 39098 
City, State, Zip:  JERUSALEM,  91390 
Telephone:  011 972-2-566-0001 
Fiscal Year:  08/31 
Last Trade
Last Trade: 
$4.92   		Change: 
0.07 (1.44%)  
Trade Time: 
Jan 26   		Market Cap: 
$53.30M
Description of Business
We are a pharmaceutical company currently engaged in the research and development of innovative pharmaceutical solutions, including an orally ingestible insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. Oral insulin: We are seeking to revolutionize the treatment of diabetes through our proprietary flagship product, an orally ingestible insulin capsule (ORMD-0801). Having completed Phase IIa clinical trials in patients with both type 1 and type 2 diabetes, we anticipate the initiation of Phase IIb clinical trials in approximately 180 patients with type 2 diabetes under an Investigational New Drug application, or IND, with the U.S. Food and Drug Administration, or FDA, in the first quarter of calendar year 2015.
Register for EDGAR Pro and access this filing in:     
  FORM 10-Q
    PART I - FINANCIAL INFORMATION
      ITEM 1 - FINANCIAL STATEMENTS
        BALANCE SHEET
        STOCKHOLDERS EQUITY
        STOCKHOLDERS EQUITY
        STOCKHOLDERS EQUITY
        CASH FLOW
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
          NOTE 6 - SUBSEQUENT EVENTS
      ITEM 2 - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL ...
      ITEM 3 - QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT ...
      ITEM 4 - CONTROLS AND PROCEDURES
    PART II - OTHER INFORMATION
      ITEM 2 - UNREGISTERED SALESES OF SECURITIES AND USE OF PROCEEDS
      ITEM 6 - EXHIBITS
    SIGNATURES
  EXHIBIT 10.1
  EXHIBIT 31.1
    CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
  EXHIBIT 31.2
    CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
  EXHIBIT 32.1
    CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
  EXHIBIT 32.2
    CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
BROKERAGE PARTNERS
© 1995-2015 EDGAR Online, Inc. All rights reserved • NASDAQ: EDGR • Solutions for Corporations • Terms of Use • Privacy Statement